Published in Brachytherapy on October 23, 2007
Dosimetric effects of prone and supine positions on post-implant assessments for prostate brachytherapy. J Contemp Brachytherapy (2013) 0.86
Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry. J Contemp Brachytherapy (2012) 0.84
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer. Radiat Oncol (2014) 0.83
Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication. Radiat Oncol (2013) 0.79
Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy. Radiat Oncol (2012) 0.77
Benefits of a dual sagittal crystal transducer for ultrasound imaging during I-125 seed implantation for permanent prostate brachytherapy. J Contemp Brachytherapy (2012) 0.76
Feasibility of vibro-acoustography with a quasi-2D ultrasound array transducer for detection and localizing of permanent prostate brachytherapy seeds: a pilot ex vivo study. Med Phys (2014) 0.75
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res (2007) 4.41
Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development (2003) 3.60
BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol (2006) 3.02
Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics (2008) 2.08
Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Mol Cancer Ther (2011) 1.66
Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg (2009) 1.62
The important role of operations in the management of anaplastic thyroid carcinoma. Surgery (2002) 1.61
Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol (2008) 1.54
Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis (2009) 1.51
MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop. Sci Signal (2011) 1.42
Coherent coupling of a superconducting flux qubit to an electron spin ensemble in diamond. Nature (2011) 1.41
Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6. Blood (2005) 1.39
Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010). Brachytherapy (2011) 1.38
Five-year potency preservation after iodine-125 prostate brachytherapy. Int J Clin Oncol (2013) 1.37
Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology (2006) 1.35
MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells. J Biol Chem (2012) 1.31
Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology (2003) 1.25
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol Rep (2010) 1.24
Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells (2004) 1.23
Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys (2008) 1.23
Dose distribution analysis of axillary lymph nodes for three-dimensional conformal radiotherapy with a field-in-field technique for breast cancer. Int J Radiat Oncol Biol Phys (2008) 1.18
Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH. Blood (2011) 1.15
Deformation of (Mg,Fe)SiO3 post-perovskite and D'' anisotropy. Science (2007) 1.13
Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol (2005) 1.11
Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease. Br J Haematol (2011) 1.10
High-throughput protein expression screening and purification in Escherichia coli. Methods (2011) 1.09
Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys (2007) 1.09
Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT. AJR Am J Roentgenol (2004) 1.07
Crystal structure and thermoelastic properties of (Mg0.91Fe0.09)SiO3 postperovskite up to 135 GPa and 2,700 K. Proc Natl Acad Sci U S A (2008) 1.06
Equation of state of the postperovskite phase synthesized from a natural (Mg,Fe)SiO3 orthopyroxene. Proc Natl Acad Sci U S A (2006) 1.06
Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity. Hepatol Res (2007) 1.05
Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Int J Radiat Oncol Biol Phys (2009) 1.03
The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Eur Urol (2012) 1.03
Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histograms. Int J Radiat Oncol Biol Phys (2004) 1.02
Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.02
Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer. Int J Radiat Oncol Biol Phys (2007) 1.01
Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg (2010) 0.99
Survival of human multiple myeloma cells is dependent on MUC1 C-terminal transmembrane subunit oncoprotein function. Mol Pharmacol (2010) 0.97
Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy--initial findings. Radiology (2005) 0.97
Sentinel nodes of malignancies originating in the alimentary tract. Ann Nucl Med (2004) 0.96
A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy. Ann Surg Oncol (2014) 0.95
Effects of single or repeated administrations of methamphetamine on immune response in mice. Exp Anim (2008) 0.95
Brachytherapy with permanent seed implantation. Int J Clin Oncol (2007) 0.94
Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction. Circ J (2009) 0.94
Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors. J Thorac Oncol (2014) 0.93
Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds. Radiat Oncol (2011) 0.92
Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys (2005) 0.92
Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am (2002) 0.92
Pattern of tumor recurrence in initially nonmetastatic breast cancer patients: distribution and frequency of metastases at unusual sites. Cancer (2008) 0.92
The value of drip infusion cholangiography using multidetector-row helical CT in patients with choledocholithiasis. Eur Radiol (2005) 0.92
Tamoxifen for recurrent desmoid tumor of the chest wall. Int J Clin Oncol (2006) 0.92
Resection of intralobar pulmonary sequestration after coil embolization of aberrant arteries: report of a case. Surg Today (2012) 0.91
Pelvic congenital arteriovenous malformation diagnosed by transrectal ultrasonography: A case report. Can Urol Assoc J (2012) 0.91
Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation. Jpn J Clin Oncol (2003) 0.90
Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system. Int J Radiat Oncol Biol Phys (2012) 0.89
Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys (2013) 0.89
Metanephric adenoma treated with laparoscopic nephrectomy. Int J Urol (2004) 0.89
Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors. Int J Radiat Oncol Biol Phys (2010) 0.89
Interim results of sentinel node biopsy during laparoscopic gastrectomy: possible role in function-preserving surgery for early cancer. World J Surg (2006) 0.89
Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis (2002) 0.89
Systematic analysis of embryonic expression profiles of zinc finger genes in Ciona intestinalis. Dev Biol (2006) 0.89
Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia. Am J Hematol (2012) 0.89
Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location. Ann Surg Oncol (2013) 0.89
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis. BJU Int (2008) 0.89
Evaluation of the dosimetric parameters for 125I brachytherapy determined in prostate medium using CT images. J Radiat Res (2010) 0.88
Use of bone SPECT in the evaluation of fibrous dysplasia of the skull. Clin Nucl Med (2004) 0.88
Contrast-enhanced ultrasonography of the prostate with Sonazoid. Jpn J Clin Oncol (2010) 0.88
Development of an ultra-high resolution SPECT system with a CdTe semiconductor detector. Ann Nucl Med (2009) 0.88
Sentinel node mapping for colorectal cancer with radioactive tracer. Dis Colon Rectum (2002) 0.88
Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines. Urology (2010) 0.87
Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein. Cancer Biol Ther (2010) 0.87
Docetaxel in combination with prednisolone for hormone refractory prostate cancer. Jpn J Clin Oncol (2009) 0.86
Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry. Jpn J Clin Oncol (2007) 0.86